SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
idahoranch1
patlawche11
To: weatherproof who wrote (38496)1/8/2017 2:00:00 AM
From: allatwwk2 Recommendations   of 63291
 
I had similar concerns to weatherproof and stated up here I would not commit my vote until after hearing from venBio.

The concerns have not gone away, but they did diminish with the cc to the point I'm comfortable committing to the venBio slate. I wouldn't say venBio was anywhere close to 'perfect' in their answers, but they did give me a sense of competence and a sense of acting in good faith.

It should be noted -- should the venBio slate be elected, the individual directors have a duty to do what is best for IMMU. Their duty in the role as directors is not to venBio.

Yes, things can go wrong with venBio and its slate -- and yes, it is possible the returns will be less with venBio. But I think there is a greater chance they will look after general shareholder interests than the current management and they have the business sense sorely lacking with the BOD and mgmt teams Doc and Cindy have assembled.

For me, at this point, it is not a close call.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext